Canine Dilated Cardiomyopathy: Lymphocyte and Cardiac α1- and β -Adrenoceptor Concentrations in Normal and Affected Great Danes

Veterinary Journal

Volumn 158, Issue 2, 1999, Pages 120-127

  Re, G ^a   Bergamasco, L ^a   Badino, P ^a   Borgarelli, M ^b   Odore, R ^a   Tarducci, A ^b   Zanatta, R ^b   Girardi, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

Dog; dilated cardiomyopathy; adrenoceptors, lymphocytes; heart.

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; PRAZOSIN; PROPANOLAMINE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHEMISTRY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DOG; DOG DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; METABOLISM; PATHOPHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOMYOPATHY, DILATED; CATECHOLAMINES; DOG DISEASES; DOGS; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MYOCARDIUM; PRAZOSIN; PROPANOLAMINES; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0033190803     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.1999.0364     Document Type: Article

References (41)

1. BENFEY B. G. Function of myocardial α -adrenoceptors. Life Sciences. 46:1990;743-757.
2. BORGARELLI M., TARDUCCI A., BUSSADORI C., RU G. Echocardiographic and echo Doppler parameters in normal Great Danes. Proceedings of 6th Annual Congress of the European Society of Veterinary Internal Medicine. September 1996:1996;12-14.
3. BRISTOW M. R. Changes in myocardial and vascular receptors in heart failure. Journal of American College of Cardiology. 22:1993;61A-71A.
4. BRISTOW M. R., GINSBURG R., MINOBE W., CUBICCIOTTI R. S., SAGEMAN W. S., LURIE K., BILLINGHAM M. E., HARRISON D. C., STINSON E. B. Decreased catecholamine sensitivity and β -adrenergic receptor density in failing human hearts. New England Journal of Medicine. 307:1982;205-211.
5. BRISTOW M. R., ANDERSON F. L., PORT J. D., SKERL L., RHERSHEBERGER R. E., LARRABE P., O'CONNEL J. B., RENLUND D. J., VOLKMAN K., MURRAY J. Differences in β -adrenergic neuroeffector mechanisms in ischemic versus dilated cardiomyopathy. Circulation. 84:1991;1024-1039.
6. 2-adrenoceptors in the human heart: properties, functions, and alterations in chronic heart failure. Pharmacological Reviews. 43:1991;203-242.
7. CARON M. G., LEFKOWITZ R. J. Catecholamine receptors: structure, function and regulation. Recent Progress in Hormone Research. 48:1993;277-290.
8. COLLINS S., CARON M. G., LEFKOWITZ R. J. From ligand binding to gene espression: new insights into the regulation of G-protein-coupled receptors. Trend in Biochemical Sciences. 17:1992;37-39.
9. DENNIS A. R., MARSH J. D., QUIGG R. J., GORDON J. B., COLUCCI W. S. β -Adrenergic receptor number and adenylate cyclase function in denervated transplantated and cardiomyopathic human heart. Circulation. 79:1989;344-349.
10. ESCHENHAGEN T., DIEDERICH M., KLUGE S. H., MAGNUSSEN O., MENDE U., MULLER F., SCHMITZ W., SCHOLZ H., WEIL J., SENT U., SCHAAD A., SCHOLTYSIK G., WUTHRICH A., GAILLARD C. Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy. Journal of Molecular and Cellular Cardiology. 27:1995;357-370.
11. 1-Adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiological Reviews. 73:1993;469-487.
12. FLORAS J. S. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. Journal of American College of Cardiology. 22:1993;72A-84A.
13. FLORAS J. S., HARA K., WIGLE E. D., DALY P., SENN B. L. M. Sympathoneural profile of patients with idiopathic dilated cardiomyopathy (IDCM). Canadian Journal of Cardiology. 7:1991;104A.
14. FOX P. R. Feline myocardial disease. Fox P. R. Canine and Feline Cardiology. 1988;435-466 Churcill Livingstone Inc. New York.
15. HAUSDORFF W. P., CARON M. G., LEFKOWITZ R. J. Turning off the signal: desensitization of β -adrenergic receptor function. FASEB Journal. 4:1990;2881-2898.
16. HEILBRUNN S. M., SHAH P., BRISTOW M. R., VALANTINE H. A., GINSBURG R., FOWLER M. B. Increased β -receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 79:1989;483-490.
17. LEFKOWITZ R. J., HOFFMAN B. B., TAYLOR P. Neurohumoral transmission: the autonomic and somatic motor nervous systems. Hardman J. G., Limbird L. E., Molinoff P. B., Ruddon R. W., Goodman Gilman A. The Pharmacological Basis of Therapeutics. 1996;105-139 McGraw-Hill, New York.
18. LEMOINE H. β -Adrenoceptor ligands: characterization and quantification of drug effects. Quantitative Structure-Activity Relationship. 11:1992;211-218.
19. LIMAS C. J., GOLDENBERG I. F., LIMAS C. Autoantibodies against β - adrenoceptors in human idiopathic dilated cardiomyopathy. Circulation Research. 64:1989;97-103.
20. LOHSE M. J. Molecular mechanisms of membrane receptor desensitization. Biochemical & Biophysical Acta. 1179:1993;171-188.
21. LOWRY O. H., ROSENBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
22. MILLIGAN G., SVOBODA P., BROWN C. M. Why are there so many adrenoceptor subtypes? Biochemical Pharmacology. 48:1994;1059-1071.
23. RE G., BADINO P., NOVELLI A., CANESE M. G., GIRARDI C. Identification of β -adrenoceptor subtypes in bovine ovarian and myometrial cell membranes. British Veterinary Journal. 151:1995;567-578.
24. RE G., BADINO P., NOVELLI A., GIRARDI C. Effects of Clenbuterol as a repartitioning agent on β -adrenoceptor concentrations in heart, bronchi, and brain of veal calves. The Veterinary Journal. 153:1997a;63-70.
25. RE G., BADINO P., BERGAMASCO L., BORGARELLI M., ODORE R., TARDUCCI A. Down regulation of lymphocyte adrenoceptor subtypes in dogs affected by dilated cardiomyopathy. Journal of Veterinary Pharmacology and Therapeutics. 20:1997b;236-237.
26. RE G., BELLOLI C., BADINO P., ARIOLI F., NOVELLI A., GIRARDI C., BERETTA C. Identification of β -adrenergic receptor subtypes mediating relaxation in isolated equine ileum. American Journal of Veterinary Research. 58:1997c;621-625.
27. SCATCHARD G. The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences. 51:1949;660-669.
28. SISSON D. D., THOMAS W. P. Myocardial diseases. Ettinger S. J., Feldman E. C. Textbook of Veterinary Internal Medicine. 1995;995-1032 W.B. Saunders Co. Philadelphia.
29. STILES G. L., CARON M. G., LEFKOWITZ M. G. β -Adrenergic receptors: biochemical mechanisms of physiological regulation. Physiological Reviews. 64:1984;661-743.
30. TALLARIDA, R. J. MURRAY, R. B. 1987, Manual of Pharmacologic Calculations with Computer Programs.
31. TANEIKE T., NARITA T., KITAZAWA T., BANDO S., TERAOKA H., OHGA A. Binding and functional characterization of alpha-2 adrenoceptors in isolated swine myometrium. Journal of Autonomic Pharmacology. 15:1995;93-105.
32. The International Small Animal Cardiac Health Council, 1992, Recommendation for the diagnosis of heart disease and treatment of heart failure in small animals, Academy of Veterinary Cardiology. San Diego, CA, 5.
33. THOMAS J. A., MARKS B. H. Plasma norepinephrine in congestive heart failure. American Journal of Cardiology. 41:1978;233-243.
34. THOMAS W. P., GABER C. E., JACOBS G. J., KAPLAN P. M., LOMBARD C. W., MOISE N., MOSES N. S. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Journal of Veterinary Internal Medicine. 7:1993;247-252.
35. TIDHOLM A., JÖNSSON L. A retrospective study of canine dilated cardiomyopathy (189 cases). Journal of the American Animal Hospital Association. 33:1997;544-550.
36. 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomiopathy: characteristics and linkage to GTP-binding protein. Circulation Research. 64:1989;474-481.
37. 2-adrenergic gene in pregnant rat myometrium. Journal of Biological Chemistry. 267:1992;7975-7978.
38. VAN VL. E. E. T, J. F., FERRANS V. J. Myocardial diseases of animals. American Journal of Pathology. 124:1986;98-157.
39. WAAGSTEIN F. Efficacy of β blockers in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. American Journal of Cardiology. 80:1997;45J-49J.
40. WARE W. A., LUND D. D., SUBIETA A. R., SCHMID P. G. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy. Journal of the American Veterinary Medical Association. 197:1990;1475-1481.
41. YAMADA S., OHKURA T., UCHIDA S., INABE K., IWATANI Y., KIMURA R., HOSHINO T., KABURAGI T. A sustained increase in β -adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy. Life Sciences. 58:1996;1737-1744.